Arthrosamid® is a new type of treatment for knee osteoarthritis that offers patients an effective alternative to the currently available therapies. Based on an innovative non-biodegradable hydrogel technology, Arthrosamid® is 97.5% water with 2.5% being a cross linked polyacrylamide backbone. When injected into the knee Arthrosamid® cushions the joint and reduces pain, providing safe and sustained relief, all with one injection.
How is Arthrosamid® administered?
How does it work?
Arthrosamid® is an intra-articular polycrylamide hydrogel injection for the symptomatic treatment of knee osteoarthritis. Once injected into the inner joint cavity, it restores viscosity within the synovial fluid, improving lubrication and cushioning of the joint. Arthrosamid® also integrates into the synovium of the inner joint capsule creating a cushion-like effect.
What are the benefits?
As Arthrosamid® works to cushion the joint, it can reduce your pain, decrease stiffness and help movement. The hydrogel itself does not degrade and therefore it provides long-acting relief, improving your quality of life. In clinical trials, patients reported a significant reduction in their pain symptoms by week 4 after their injection and unlike other injectable treatments, the level of reduction was maintained at the 1 year follow up period.